Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001799191-24-000015

Director returned 18,121 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Hively Brad · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-06-17 Returned to the company : show line 1 in the form −18,121 $0.46 $8,296 676,203 D
Loading xslF345X05/edgardoc.xml…